Race Oncology Ltd (RAC) — Cash Flow-to-Debt Ratio
Race Oncology Ltd (RAC) has a Cash Flow-to-Debt Ratio of -1.83x as of December 2025, meaning its operating cash flow of AU$-2.19 Million could theoretically repay -2% of its total liabilities (AU$1.20 Million) in one year. Explore Race Oncology Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Race Oncology Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Race Oncology Ltd across 16 annual periods. Also explore how large is Race Oncology Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Race Oncology Ltd (2011–2025)
Year-by-year debt coverage analysis for Race Oncology Ltd. For market capitalisation and broader financial context, see Race Oncology Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.09x | AU$-4.57 Million | AU$1.48 Million | ▲ +37.9% |
| 2024 | -4.98x | AU$-9.55 Million | AU$1.92 Million | ▲ +46.1% |
| 2023 | -9.25x | AU$-10.65 Million | AU$1.15 Million | ▼ -109.5% |
| 2022 | -4.42x | AU$-6.26 Million | AU$1.42 Million | ▲ +50.8% |
| 2021 | -8.98x | AU$-4.70 Million | AU$523.11K | ▲ +11.2% |
| 2020 | -10.11x | AU$-2.46 Million | AU$243.65K | ▲ +27.4% |
| 2019 | -13.92x | AU$-2.67 Million | AU$192.12K | ▼ -11.4% |
| 2018 | -12.49x | AU$-3.87 Million | AU$309.71K | ▼ -84.2% |
| 2017 | -6.78x | AU$-2.47 Million | AU$363.57K | ▼ -767.9% |
| 2016 | -0.78x | AU$-306.06K | AU$391.62K | ▲ +10.5% |
| 2015 | -0.87x | AU$-103.69K | AU$118.78K | ▼ -191.4% |
| 2014 | -0.30x | AU$-39.56K | AU$132.05K | ▼ -1642.5% |
| 2013 | 0.02x | AU$3.71 Million | AU$191.01 Million | ▲ +112.1% |
| 2013 | -0.16x | AU$-1.90K | AU$11.85K | ▼ -894.7% |
| 2012 | 0.02x | AU$6.68 Million | AU$331.51 Million | ▼ -53.8% |
| 2011 | 0.04x | AU$11.92 Million | AU$273.20 Million | — |